SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

KalVista CMO Sells Stock

KalVista Pharmaceuticals CMO sells shares worth $71,916, potentially indicating insider activity

KALV

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.